The incidence of stroke is on the rise in Taiwan, driven by unhealthy eating habits, the prevalence of cigarette smoking and high alcohol consumption. A new study presented at the ASEAN Federation of Cardiology Congress in September found the disease that affects... Read More
As the pharmaceutical industry’s expansion into emerging markets meets the desire of Asian governments to speed approval of innovative products, demand for clinical trials is soaring in the Asian region. By 2021, the global market for clinical trials is expected to reach... Read More
Taiwan’s Ministry of Health and Welfare (MOHW) is the government ministry responsible for the country’s healthcare regulations. The MOHW has a broad mandate to improve the quality of healthcare, prevent and control infectious diseases, ensure food and drug safety, and facilitate technological... Read More
An alarming jump in mental illness in some of Asia’s fastest developing countries has made the region the third largest market in the world for mental health therapeutics, even as social stigma and lack of professional services leave a majority of the... Read More
This article was originally published on MedTech Intelligence. Driven largely by hepatitis in its various forms, liver disease has long been a fixture of life in China and Southeast Asia. Over the past three decades, public health programs in the region have... Read More
Taiwan’s parliament has passed a bill that establishes new protections for the intellectual property of pharmaceutical companies. The new “patent linkage” system, modeled on the U.S. “Orange Book” approach, is aimed at preventing licenses from being issued for drugs that infringe on... Read More
The rise of more advanced treatments and medical facilities in Asia is driving strong growth in the market for endoscopic devices, according to a report by Transparency Market Research. The use of endoscopic devices in the diagnosis of various diseases and infections... Read More
The Taiwan Food and Drug Administration (TFDA) said in January 2018 that it approved 20 percent more new drug licenses in 2017 compared to the previous year. The major therapeutic areas of the approved drugs were cancer therapies, rare diseases, diabetes, cardiovascular... Read More
This article was originally published on MedTech Intelligence. From manufacturing medical devices and dental implants to bioprinting organs for transplant, 3-D printing is on the verge of revolutionizing healthcare in the coming years. With the 3-D printing market for medical devices alone expected... Read More
The Asia-Pacific medical imaging market is expected to grow at a compound annual growth rate of about 10 percent from 2017 to 2021, according to a report by Technavio. The growth is being driven by technological advancements such as 4-D medical imaging,... Read More